Yifeng Pharmacy to cancel restricted stock after employee departures

Yifeng Pharmacy Chain (SSE:603939) announced it will repurchase and cancel 16,688 restricted shares on March 25, 2025. The shares were initially granted under the company's 2022 restricted stock incentive plan. The decision follows the departure or demotion of five employees who no longer meet the plan's vesting requirements. The repurchase and cancellation were approved at the company’s board meeting on January 27, 2025. After the cancellation, the remaining restricted stock under the 2022 incentive plan will total 222,354 shares. Post-cancellation, Yifeng Pharmacy's total share capital will be 1,212,416,000 shares, with 222,354 restricted shares and 1,212,193,646 unrestricted shares.